Adenylyl cyclase type 6 overexpression selectively enhances β-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 4-6, 2008, Pages 359-369

  Liu, Xiaoqiu ^a   Thangavel, Muthusamy ^a   Sun, Shu Qiang ^a   Kaminsky, Joseph ^a   Mahautmr, Penden ^a   Stitham, Jeremiah ^b   Hwa, John ^b   Ostrom, Rennolds S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Caveolae; Collagen; Fibrosis; PGE2; PGI2

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENYLATE CYCLASE; ADENYLATE CYCLASE 6; BERAPROST; BETA ADRENERGIC RECEPTOR; BUTAPROST; COLLAGEN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; ISOPRENALINE; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN E RECEPTOR;

ANIMAL CELL; CELL ULTRASTRUCTURE; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; FIBROBLAST; HEART FIBROBLAST; LIPID RAFT; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

ADENYLATE CYCLASE; ANIMALS; CERCOPITHECUS AETHIOPS; COLLAGEN; COS CELLS; CYCLIC AMP; FIBROBLASTS; GENE EXPRESSION; MALE; MEMBRANE MICRODOMAINS; MICE; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 45749129007     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0196-0     Document Type: Conference Paper

References (38)

1. Anderson RG (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225
2. Block JA, Sequeira W (2001) Raynaud's phenomenon. Lancet 357(9273):2042-2048
3. Brunton LL, Hayes JS et al (1981) Functional compartmentation of cyclic AMP and protein kinase in heart. Adv Cycl Nucleotide Res 14:391-397
4. Bundey RA, Insel PA (2006) Adenylyl cyclase 6 overexpression decreases the permeability of endothelial monolayers via preferential enhancement of prostacyclin receptor function. Mol Pharmacol 70(5):1700-1707
5. Cooper DM (2003) Regulation and organization of adenylyl cyclases and cAMP. Biochem J 375(Pt 3):517-529
6. Davare MA, Avdonin V et al (2001) A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science 293(5527):98-101
7. Eghbali M, Weber KT (1990) Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 96(1):1-14
8. Fagan KA, Smith KE et al (2000) Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domains. J Biol Chem 275(34):26530-26537
9. Foster LJ, De Hoog CL et al (2003) Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100(10):5813-5818
10. Gao M, Ping P et al (1998) Increased expression of adenylyl cyclase type VI proportionately increases beta-adrenergic receptorstimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 95(3):1038-1043
11. Gros R, Ding Q et al (2006) Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization. Circ Res 99(8):845-852
12. Gustafsson AB, Brunton LL (2000) Beta -adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization. Mol Pharmacol 58(6):1470-1478
13. Hasse A, Nilius SM et al (2003) Long-term-desensitization of prostacyclin receptors is independent of the C-terminal tail. Biochem Pharmacol 65(12):1991-1995
14. Liu X, Ostrom RS et al (2004) cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol Cell Physiol 286(5):C1089-C1099
15. Liu X, Sun SQ et al (2006) cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Mol Pharmacol 70(6):1992-2003
16. McAdam BF, Catella-Lawson F et al (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96(1):272-277
17. Narumiya S, Sugimoto Y et al (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193-1226
18. Nasrallah R, Hebert RL (2005) Prostacyclin signaling in the kidney: implications for health and disease. Am J Physiol Renal Physiol 289(2):F235-246
19. Ostrom RS, Insel PA (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: Implications for molecular pharmacology. Br J Pharmacol 143(2):235-245
20. Ostrom RS, Gregorian C et al (2000) Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem 275(16):11735-11739
21. Ostrom RS, Post SR et al (2000) Stoichiometry and compartmentation in G Protein-coupled receptor signaling: implications for therapeutic interventions involving Gs. J Pharmacol Exp Ther 294(2):407-412
22. Ostrom RS, Violin JD et al (2000) Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57(5):1075-1079
23. Ostrom RS, Gregorian C et al (2001) Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem 276(45):42063-42069
24. Ostrom RS, Liu X et al (2002) Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62(5):983-992
25. Ostrom RS, Naugle JE et al (2003) Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts. J Biol Chem 278(27):24461-24468
26. Pike LJ (2003) Lipid rafts: bringing order to chaos. J Lipid Res 44(4):655-667
27. Razani B, Woodman SE et al (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54(3):431-467
28. Rubin LJ, Groves BM et al (1982) Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension. Circulation 66(2):334-338
29. Rybin VO, Xu X et al (2000) Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275(52):41447-41457
30. Schwencke C, Yamamoto M et al (1999) Compartmentation of cyclic adenosine 3′,5′-monophosphate signaling in caveolae. Mol Endocrinol 13(7):1061-1070
31. Shaul PW (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-774
32. Shaul PW, Smart EJ et al (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271(11):6518-6522
33. Smith KE, Gu C et al (2002) Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca2+ entry. J Biol Chem 277(8):6025-6031
34. Song SK, Li S et al (1996) Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271(16):9690-9697
35. Steinberg SF, Brunton LL (2001) Compartmentation of g protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41:751-773
36. Swaney JS, Roth DM et al (2005) Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci USA 102(2):437-442
37. Weber KT, Sun Y et al (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26(3):279-292
38. Yu H, Gallagher AM et al (1997) Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension 30(5):1047-1053